Volume 95, Issue 4, Pages (April 2019)

Slides:

Advertisements

Similar presentations

National Guidelines for Nursing Delegation

Advertisements

A Nurr1 Pathway for Neuroprotection

Of Worms and Men: HLH-30 and TFEB Regulate Tolerance to Infection

Figure 4 Simplified T cell and antigen presenting

Novel SIRT1 Mutation Linked to Autoimmune Diabetes in Humans

Volume 92, Issue 1, Pages 2-3 (July 2017)

Axonally Translated SMADs Link Up BDNF and Retrograde BMP Signaling

Mutant p53 gain of function: The NF-Y connection

NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner Hans-Joachim Anders, Maciej.

Nuclear Factor-κB Pathway–Activating Gene Aberrancies in Primary Cutaneous Large B-Cell Lymphoma, Leg Type Lianne Koens, Willem H. Zoutman, Passorn Ngarmlertsirichai,

Toll-like Receptors Keep Antigen Sorting on the Right Track

New class of anti-inflammatory agents for colonic epithelial cells

p53 and Apoptosis: It's Not Just in the Nucleus Anymore

Toll-like Receptor 9, What O'Clock Is It?

Toll-like receptor activation: from renal inflammation to fibrosis

Volume 147, Issue 3, Pages (September 2014)

From Prescription to Transcription: Genome Sequence as Drug Target

T Helper 17 Cells Get the NOD

Dysfunctional HDL Takes Its Toll in Chronic Kidney Disease

Innate immunity as a driving force in renal disease

Andrew Blauvelt, Mark G. Lebwohl, Robert Bissonnette

Volume 91, Issue 3, Pages (March 2017)

Volume 94, Issue 4, Pages (October 2018)

Volume 93, Issue 4, Pages (April 2018)

Foxo1 and Foxo3 help Foxp3 Immunity

Signalling pathways in alcohol-induced liver inflammation

Apoptosis-targeted therapies for cancer

Inhibition of mammalian target of rapamycin: Two goals with one shot?

Volume 91, Issue 1, Pages 2-3 (January 2017)

Linking gene expression, nuclear factor kappa B, remote ischemic preconditioning, and transplantation: A quest for an elusive Holy Grail or a road to.

Eukaryotic Transcription Activation: Right on Target

Volume 71, Issue 8, Pages (April 2007)

Stop that Noise and Turn Up the Antisense Transcription

Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets

Volume 92, Issue 4, Pages (October 2017)

Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome

John G. Monroe, Mary E. Keir Immunity

Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma Sean Whittaker Journal of.

Experimental Hematology

Volume 89, Issue 5, Pages (May 2016)

Killing Lymphoma with Smac-Mimetics: As Easy as ABC?

Volume 91, Issue 5, Pages (May 2017)

You AhR What You Eat: Linking Diet and Immunity

Singular Expression of Olfactory Receptor Genes

Regulation of Organelle Biogenesis

Proteins Kinases: Chromatin-Associated Enzymes?

Volume 95, Issue 3, Pages (March 2019)

Dolors Colomer, Elías Campo Cancer Cell

Volume 94, Issue 6, Pages (December 2018)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Calcium sensing in podocytes

Fibronectin at Select Sites Binds Multiple Growth Factors and Enhances their Activity: Expansion of the Collaborative ECM-GF Paradigm Jia Zhu, Richard.

Volume 75, Issue 9, Pages (May 2009)

Cytokine Signaling Modules in Inflammatory Responses

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Volume 70, Issue 3, Pages (August 2006)

Appendix D – Survey Questionnaire

Jamie E. McInturff, Robert L. Modlin, Jenny Kim

Volume 22, Issue 4, Pages (April 2018)

NF-κB Regulation by NLRs: T Cells Join the Club

Mesenchymal Stromal Cells: New Directions

Volume 75, Issue 8, Pages (April 2009)

Volume 72, Issue 8, Pages (October 2007)

TAMpering with Toll-like Receptor Signaling

Dysfunctional HDL Takes Its Toll in Chronic Kidney Disease

Volume 96, Issue 1, Pages 5-7 (July 2019)

Volume 147, Issue 3, Pages (September 2014)

Ibrutinib Treatment of CLL: The Cancer Fights Back

In This Issue Cell Volume 145, Issue 3, (April 2011)

Presentation transcript:

Volume 95, Issue 4, Pages 724-726 (April 2019) Journal Club Kidney International Volume 95, Issue 4, Pages 724-726 (April 2019) DOI: 10.1016/j.kint.2019.02.006 Copyright © 2019 Terms and Conditions

Figure 1 A pathway-level map reveals specific targets of glucocorticoid action on individual cell types. (a) Pathways (rows) affected by glucocorticoid treatment of specific cell types (columns) arranged in modules of similar cell-type specificity. (b) Transcriptional effects of glucocorticoids on genes involved in B-cell receptor (BCR) signaling. (c) Transcriptional effects of glucocorticoids on genes involved in Toll-like receptor (TLR) signaling. Reprinted from Franco LM, Gadkari M, Howe KN, et al. Immune regulation by glucocorticoids can be linked to cell type–dependent transcriptional responses. J Exp Med. 2019;216: 384–406. Copyright © 2019 Franco et al. https://doi.org/10.1084/jem.20180595. ECM, extracellular matrix; GC, glucocorticoid, NFκB, nuclear factor kappa B. Kidney International 2019 95, 724-726DOI: (10.1016/j.kint.2019.02.006) Copyright © 2019 Terms and Conditions